Suchergebnisse - "Myeloma"

PubPharm (2)

1

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR) : a randomised, phase 3, open-label, multicentre study

enthalten in: The lancet / Oncology | 2016

von Dimopoulos, M. | Goldschmidt, H.

2

Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14)

enthalten in: Bone marrow transplantation | 24 September 2007

von Hundemer, M. | Klein, U. | Hose, D. | +8

1
[1]